Evidence map›Paper›PMID 41896723›Full record

ArticleThe journal of headache and pain2026

Epimutations in migraine and in medication overuse headache: a longitudinal study after acute medication withdrawal.

Francesca Ferraresi, Valentina Favoni, Davide Mascarella, Chiara Pirazzini, Katarzyna Malgorzata Kwiatkowska, Francesco Ravaioli, Maria Giulia Bacalini, Daniele Dall'olio, Gastone Castellani, Claudia Sala and 7 more

Abstract read
In one paragraph

Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Francesca Ferraresi *Department of Chemistry "Giacomo Ciamician", University of Bologna, 40126, Bologna, Italy. francesca.ferraresi6@unibo.it.
Valentina Favoni *IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Davide MascarellaIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Chiara PirazziniDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Katarzyna Malgorzata KwiatkowskaDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Francesco RavaioliIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Maria Giulia BacaliniIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Daniele Dall'olioDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Gastone CastellaniDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Claudia SalaDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Giulia PierangeliDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40138, Bologna, Italy.
Pietro CortelliDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40138, Bologna, Italy.
Davide GentiliniDepartment of Brain and Behavioral Sciences, University of Pavia, 27100, Pavia, Italy.
Luciano CalzariBioinformatics and Statistical Genomics Unit, Istituto Auxologico Italiano IRCCS, 20095, Cusano Milanino, Milan, Italy.
Rossana TerlizziDepartment of Neurosciences, Neurology and Stroke Unit, Bufalini Hospital, AUSL Romagna, Cesena, Italy.
Paolo Garagnani *Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy.
Sabina Cevoli *IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeadache disorders are among the leading causes of neurological disability worldwide, affecting over half of the global population. Recent data indicate that headache prevalence among young people increased by 23.7% between 1990 and 2021. Migraine, a highly disabling primary headache, significantly impacts daily life, yet timely and accurate diagnosis remains challenging. Many patients self-manage with analgesics, contributing to medication-overuse headache (MOH), which affects 1–2% of the general population. Emerging evidence suggests that epigenetic mechanisms, particularly DNA methylation (DNAm), play a key role in the pathophysiology of migraine and MOH.

methodsWe investigated epigenetic entropy by calculating Stochastic Epigenetic Mutations (SEMs) and epivariations in 57 participants of the longitudinal Epimode project. Patients were enrolled in three groups: Chronic Migraine with MOH (assessed before and at various timepoints after clinical treatment), Episodic Migraine (EM; assessed at baseline and follow-up), and Healthy Controls (HC; assessed at baseline and follow-up). Peripheral blood DNA methylation was analysed genome-wide, and SEMs were annotated by genomic context and functional category. Statistical analyses assessed group differences and temporal dynamics of SEMs.

resultsAt baseline (T0), both EM and MOH patients exhibited significantly higher SEMs counts compared with HC, with no differences between EM and MOH groups, either in total counts or in hypo-/hypermethylated CpGs. Differences persisted across functional categories and chromosomes. Overall, no significant changes in SEMs counts were observed in MOH patients pre- and post-treatment overall. However, MOH non-responders displayed high SEMs counts at T0 and the greatest reshuffling rate between lost, maintained and gained SEMs over time. Enrichment analyses identified SEMs in genes associated with metabolic, synaptic, and inflammatory function.

conclusionThese findings indicate that migraine promotes epigenetic entropy and suggest that epigenetic instability contributes to headache chronification and treatment resistance. Moreover, the dynamics of SEMs over time provide more informative insights than absolute counts alone in evaluating clinical outcomes. This study reinforces the relevance of epigenetic mechanisms in the clinical management of headache disorders.

Indexed as

AnalgesicsDNA MethylationEpigenesis, GeneticHeadache Disorders, SecondaryMigraine DisordersAdultFemaleHumansLongitudinal StudiesMaleMiddle AgedMutationAnalgesicsDNA methylationHeadacheMedication overuseMigraineStochastic epigenetic mutations

Identifiers

PMID41896723
PMCPMC13077941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.